Picard Announces Appointment of Two New Members to its Board of Directors

TUCSON, Ariz., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and Canadian commercially-approved total artificial heart, today announced the appointment of two new members that will serve on its Board of Directors, Sam Van and George Ye. Both were appointed following the closing of the initial public offering and have deep leadership experience in complementary areas to advise the company in its next stage as a public company.

Read more at globenewswire.com